7-03-2023, 05:02

Carriage Services Appoints Kian Granmayeh as Chief

HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE:CSV) Carriage Services, Inc. (“Carriage”
Globe Newswire7-03-2023, 05:02
7-03-2023, 04:47

Oportun to Report Fourth Quarter 2022 Financial Results on

SAN CARLOS, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech and digital
Globe Newswire7-03-2023, 04:47
7-03-2023, 04:30

Superior Group of Companies to Announce Fourth Quarter and

SEMINOLE, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”)
Globe Newswire7-03-2023, 04:30
7-03-2023, 04:09

Avid Bioservices to Report Financial Results for Third

TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics
Globe Newswire7-03-2023, 04:09
7-03-2023, 00:09

Amy Somerville Ushered in as CEO of SUCCESS Enterprises To

Somerville brings extensive leadership experience, media prowess and proven track record of changing lives...
Globe Newswire7-03-2023, 00:09
6-03-2023, 20:56

Hyperfine, Inc. to Announce Fourth Quarter and Full Year

GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device
Globe Newswire6-03-2023, 20:56
6-03-2023, 19:34

Bath & Body Works Announces Appointment of Thomas J. Kuhn

Experienced Financial and Governance Advisor Brings 35 Years of Experience to Board...
Globe Newswire6-03-2023, 19:34
6-03-2023, 18:39

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused
Globe Newswire6-03-2023, 18:39
6-03-2023, 16:36

Himax Technologies, Inc. to Attend 26th Credit Suisse Asian

TAINAN, Taiwan, March 06, 2023 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a
Globe Newswire6-03-2023, 16:36
6-03-2023, 02:01

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data
Globe Newswire6-03-2023, 02:01
5-03-2023, 01:31

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic
Globe Newswire5-03-2023, 01:31
4-03-2023, 09:41

HII Hosts Chief of Naval Operations Adm. Michael Gilday at

NEWPORT NEWS, Va., March 03, 2023 (GLOBE NEWSWIRE) -- HII (NYSE: HII) hosted Chief of Naval Operations Adm. Michael
Globe Newswire4-03-2023, 09:41